跳至主要内容
临床试验/JPRN-jRCTs032220082
JPRN-jRCTs032220082已完成未知

Development of an automated delivery system of vasoactive drug for stable blood pressure

agata Osamu0 个研究点目标入组 20 人开始时间: 2022年5月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

This study confirmed that a very high percentage of patients develop hypotension during general anesthesia, that the automatic administration control system for circulatory agonists works properly, and that adjustment of the administration of circulatory agonists by the automatic administration control system when abnormal hypotension is observed is no less effective than anesthesiologists' administration of circulatory agonists to recover from abnormal hypotension.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • (1) Males and females patients over 20 years old at the time of informed consent
  • (2) Patients with ASA Physical Status of 1, 2, and 3 who are scheduled for surgery under general anesthesia with propofol, remifentanil, and rocuronium
  • (3) Patients who understand the contents of this study and are willing to provide written informed consent for participation in this study

排除标准

  • (1) Patients with a history of hypersensitivity to propofol, remifentanil, rocuronium, sugammadex, circulatory agonists (phenylephrine, noradrenaline, etc.), or infusion products
  • (2) Patients who cannot have a bispectral index (BIS) sensor applied intraoperatively
  • (3) Patients who cannot receive additional doses of rocuronium after the initial single dose
  • (4) Patients who cannot have their blood pressure measured non-invasively during surgery
  • (5) Patients undergoing surgery with hypothermia
  • (6) Patients undergoing cardiovascular surgery
  • (7) Patients who are pregnant or lactating
  • (8) Patients with severely depressed cardiac function (EF less than 40%) or with ventricular tachycardia, or a history of coronary intervention within the last 3 months
  • (9) Patients who are determined not to be eligible for participation in this study by the research director

研究者

发起方
agata Osamu

相似试验